To test this hypothesis, we aimed to explore the involvement of PLXNA4 variants in the underlying pathogenesis of AD, by investigating the effects of PLXNA4 polymorphisms on the brain amyloid burden through CSF phenotypes in the ADNI dataset. Here, PLXNA4 is linked to Alzheimer disease.